GT-007 (GRIT Biotechnology)

N/A

Report date: 2023/12/15 16:33:29

Base Information

Drug NameGT-007 (GRIT Biotechnology)

Drug Alias NameGT-007GT 007

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Tumor Infiltrating Lymphocytes

Mechanisms of ActionImmunologic cytotoxicityT lymphocyte replacements

TargetsNot applicable

Therapy Area/IndicationsHematologic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaPreclinical

Originator Companiesshenzhen Grit Biotechnology Co Ltd

China Registration ClassN/A

Develop Information

Active Companiesshenzhen Grit Biotechnology Co Ltd

Inactive CompaniesN/A

Active IndicationsHematologic Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A